{"cited_by_count":3783438,"description":"This cluster of papers focuses on various aspects of HIV/AIDS, including immune activation, vaccine development, viral reservoirs, antiretroviral therapy, and the immune response to HIV infection. It also covers topics related to neurocognitive disorders associated with HIV, antibodies targeting HIV, and the development of potential therapeutic interventions.","display_name":"HIV Research and Treatment","domain_id":"1","external_ids":{"openalex":"https://openalex.org/T10112","wikipedia":"https://en.wikipedia.org/wiki/HIV/AIDS"},"field_id":"24","id":"T10112","keywords":[{"display_name":"HIV-1","id":"hiv-1","score":0.5452,"url":"https://openalex.org/keywords/hiv-1"},{"display_name":"HIV-1 infection","id":"hiv-1-infection","score":0.433,"url":"https://openalex.org/keywords/hiv-1-infection"},{"display_name":"simian immunodeficiency virus","id":"simian-immunodeficiency-virus","score":0.7804,"url":"https://openalex.org/keywords/simian-immunodeficiency-virus"},{"display_name":"HIV-associated neurocognitive disorders","id":"hiv-associated-neurocognitive-disorders","score":0.6481,"url":"https://openalex.org/keywords/hiv-associated-neurocognitive-disorders"},{"display_name":"HIV vaccine","id":"hiv-vaccine","score":0.6562,"url":"https://openalex.org/keywords/hiv-vaccine"},{"display_name":"gp120","id":"gp120","score":0.7539,"url":"https://openalex.org/keywords/gp120"},{"display_name":"HIV-1 envelope glycoprotein","id":"hiv-1-envelope-glycoprotein","score":0.7492,"url":"https://openalex.org/keywords/hiv-1-envelope-glycoprotein"},{"display_name":"HIV reservoir","id":"hiv-reservoir","score":0.8419,"url":"https://openalex.org/keywords/hiv-reservoir"},{"display_name":"HIV-2","id":"hiv-2","score":0.5543,"url":"https://openalex.org/keywords/hiv-2"},{"display_name":"HIV-1 vaccine","id":"hiv-1-vaccine","score":0.847,"url":"https://openalex.org/keywords/hiv-1-vaccine"},{"display_name":"HIV cure","id":"hiv-cure","score":0.7934,"url":"https://openalex.org/keywords/hiv-cure"},{"display_name":"broadly neutralizing antibodies","id":"broadly-neutralizing-antibodies","score":0.6264,"url":"https://openalex.org/keywords/broadly-neutralizing-antibodies"},{"display_name":"CCR5","id":"ccr5","score":0.2918,"url":"https://openalex.org/keywords/ccr5"},{"display_name":"HIV-1 replication","id":"hiv-1-replication","score":0.7241,"url":"https://openalex.org/keywords/hiv-1-replication"},{"display_name":"HIV pathogenesis","id":"hiv-pathogenesis","score":0.7975,"url":"https://openalex.org/keywords/hiv-pathogenesis"},{"display_name":"HIV latency","id":"hiv-latency","score":0.8379,"url":"https://openalex.org/keywords/hiv-latency"},{"display_name":"envelope glycoprotein","id":"envelope-glycoprotein","score":0.4586,"url":"https://openalex.org/keywords/envelope-glycoprotein"},{"display_name":"HIV-associated dementia","id":"hiv-associated-dementia","score":0.6652,"url":"https://openalex.org/keywords/hiv-associated-dementia"},{"display_name":"HIV-1 subtypes","id":"hiv-1-subtypes","score":0.5507,"url":"https://openalex.org/keywords/hiv-1-subtypes"},{"display_name":"gp41","id":"gp41","score":0.7493,"url":"https://openalex.org/keywords/gp41"},{"display_name":"chronic HIV infection","id":"chronic-hiv-infection","score":0.6637,"url":"https://openalex.org/keywords/chronic-hiv-infection"},{"display_name":"viral reservoir","id":"viral-reservoir","score":0.4554,"url":"https://openalex.org/keywords/viral-reservoir"},{"display_name":"HIV-1 Tat protein","id":"hiv-1-tat","score":0.4403,"url":"https://openalex.org/keywords/hiv-1-tat"},{"display_name":"V3 loop","id":"v3-loop","score":0.8649,"url":"https://openalex.org/keywords/v3-loop"},{"display_name":"HIV disease progression","id":"hiv-disease-progression","score":0.4413,"url":"https://openalex.org/keywords/hiv-disease-progression"}],"legacy_keywords":["HIV","AIDS","vaccine","antibodies","immune activation","neurocognitive disorders","viral reservoir","T cell","antiretroviral therapy","immune response"],"openalex_id":"https://openalex.org/T10112","source_created_date":"2024-01-23T15:27:05","source_updated_date":"2026-10-17T03:02:00","subfield_id":"2406","url":"/topics/T10112","works_api_url":"https://api.openalex.org/works?filter=topics.id:T10112","works_count":151955,"label":"HIV Research and Treatment","provider":"openalex","revision":"48d5b9c9d55f942e","taxonomy_revision":"f050b5d4780b1289","title":"HIV Research and Treatment","kind":"topic-directory","aeo_cohort":"topic-directory","catalogue_revision":"f050b5d4780b1289","numeric_address":"36108565370512449","address_version":"morton4x16-v1","coordinates":[1,24,2406,10112],"answer_status":"Directory metadata; local answer requires separate source review","truth_status":"Subject descriptor, not a factual answer or a demonstrated knowledge gap","reviewed_answer":null}